| Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma PA Philip, I Azar, J Xiu, MJ Hall, AE Hendifar, E Lou, JJ Hwang, J Gong, ... Clinical Cancer Research 28 (12), 2704-2714, 2022 | 113 | 2022 |
| p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes T Mesplède, D Gagnon, F Bergeron-Labrecque, I Azar, H Sénéchal, ... Journal of virology 86 (1), 94-107, 2012 | 110 | 2012 |
| Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer I Azar, S Alkassis, J Fukui, F Alsawah, K Fedak, MN Al Hallak, A Sukari, ... Lung Cancer: Targets and Therapy, 103-114, 2021 | 33 | 2021 |
| Treatment and survival rates of stage IV pancreatic cancer at VA hospitals: a nation-wide study I Azar, G Virk, S Esfandiarifard, A Wazir, S Mehdi Journal of Gastrointestinal Oncology 10 (4), 703, 2019 | 33 | 2019 |
| HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs SM Daniels, L Sinck, NJ Ward, CE Melendez-Peña, RJ Scarborough, ... RNA biology 12 (2), 123-135, 2015 | 24 | 2015 |
| Therapy for stage IV non–small cell lung cancer with driver alterations: ASCO living guideline, version 2023.3 IA Jaiyesimi, NB Leighl, N Ismaila, K Alluri, N Florez, S Gadgeel, ... Journal of clinical oncology 42 (11), e1-e22, 2024 | 21 | 2024 |
| The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis I Azar, N Al Masalmeh, S Esfandiarifard, G Virk, W Kiwan, A Frank Shields, ... Cancer medicine 10 (9), 2987-2995, 2021 | 15 | 2021 |
| Comparison of carboplatin with cisplatin in small cell lung cancer in US veterans I Azar, O Yazdanpanah, H Jang, A Austin, S Kim, J Chi, S Alkassis, ... JAMA Network Open 5 (10), e2237699-e2237699, 2022 | 12 | 2022 |
| Sunitinib‐Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient I Azar, S Esfandiarifard, P Sinai, A Wazir, L Foulke, S Mehdi Case Reports in Oncological Medicine 2017 (1), 6328204, 2017 | 11 | 2017 |
| Squamous cell lung carcinoma presenting as melena: a case report and review of the literature I Azar, E Koutroumpakis, R Patel, S Mehdi Rare Tumors 9 (3), 85-88, 2017 | 9 | 2017 |
| Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers HY Khan, M Nagasaka, A Aboukameel, O Alkhalili, MH Uddin, ... Molecular Cancer Therapeutics 22 (12), 1422-1433, 2023 | 7 | 2023 |
| Xylophagia (paper eating): A rare form of pica D Kurtz, I Azar, H Khan, K Lilley, I Woldie Clinical Case Reports 8 (12), 3546-3547, 2020 | 5 | 2020 |
| Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model MH Uddin, MN Al‐Hallak, HY Khan, A Aboukameel, Y Li, SF Bannoura, ... Clinical and Translational Medicine 13 (12), e1513, 2023 | 4 | 2023 |
| Durvalumab-induced hyperprogressive disease in nonmetastatic lung cancer TJ Khreis, IH Azar, R Patel, SA Mehdi Journal of Oncology Practice 15 (4), 217-219, 2019 | 3 | 2019 |
| Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009 I Azar, S Esfandiarifard, P Sinai, S Mehdi Cancer 124 (13), 2858-2858, 2018 | 3 | 2018 |
| Abstract B077: KRASG12D inhibitor MRTX1133 synergizes with the next generation nuclear transport protein inhibitor eltanexor resulting in enhanced antitumor … HY Khan, A Aboukameel, MH Uddin, MN Al-Hallak, EW Beal, I Azar, ... Cancer Research 84 (2_Supplement), B077-B077, 2024 | 2 | 2024 |
| The Role of Surgery in Stage I Small Cell Lung Cancer: A National VA Database Analysis I Azar, A Austin, BK Saha, S Kim, H Jang, A Al Sbihi, S Alkassis, ... Clinical Lung Cancer 24 (5), e179-e186, 2023 | 2 | 2023 |
| Preferences and attitudes of cardiologists in management of patients with cancer I Azar, S Wang, V Dhillon, J Kenitz, D Lombardo, R Deano, S Mahmood, ... Palliative Medicine Reports 3 (1), 279-286, 2022 | 2 | 2022 |
| Cisplatin versus carboplatin for the treatment of limited-stage small cell lung cancer (LS-SCLC). I Azar, A Austin, S Kim, H Jang, M Surapaneni, D Kurtz, O Yazdanpanah, ... Journal of Clinical Oncology 39 (15_suppl), 8565-8565, 2021 | 2 | 2021 |
| Carboplatin versus cisplatin for the treatment of extensive-stage small cell lung cancer (SCLC): A National VA Database analysis. I Azar, A Austin, S Kim, H Jang, A Chopra, SA Mehdi, H Mamdani Journal of Clinical Oncology 38 (15_suppl), 9061-9061, 2020 | 2 | 2020 |
Hirva MamdaniKarmanos Cancer Institute/Wayne State University在 karmanos.org 的电子邮件经过验证
